Mesothelioma is a killer of urban men in Sweden.

Re: Mesothelioma is a killer of urban men in Sweden by Kari Hemminki and Xinjun Li. Int J Cancer (2003) 0.75

Geographic distribution of incident mesothelioma in Connecticut men, 1990-99. Int J Cancer (2003) 0.75

TERT promoter mutations in familial and sporadic melanoma. Science (2013) 7.82

Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26

New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15

Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer (2002) 3.55

BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res (2003) 3.21

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet (2010) 2.47

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood (2007) 2.31

Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst (2005) 2.23

Cancer risks in first-generation immigrants to Sweden. Int J Cancer (2002) 2.16

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics (2008) 2.11

Familial renal cell carcinoma from the Swedish Family-Cancer Database. Eur Urol (2011) 2.10

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis (2008) 2.09

Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood (2004) 2.05

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90

SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis (2008) 1.84

Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet (2011) 1.83

Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Oncogene (2003) 1.82

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A (2013) 1.82

Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol (2004) 1.80

Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis (2003) 1.78

Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74

Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73

Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum (2009) 1.73

Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73

SNP microarray analysis for genome-wide detection of crossover regions. Hum Genet (2005) 1.68

BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J Invest Dermatol (2005) 1.66

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis. PLoS One (2007) 1.65

Neighborhood violent crime and unemployment increase the risk of coronary heart disease: a multilevel study in an urban setting. Soc Sci Med (2005) 1.65

Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood (2009) 1.64

Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control (2007) 1.61

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer (2006) 1.61

Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60

Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays. Am J Hum Genet (2006) 1.60

Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer (2004) 1.56

Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54

The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis (2002) 1.53

Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum (2008) 1.50

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis (2005) 1.48

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol (2007) 1.47

Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45

Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum (2009) 1.45

Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 1.45

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood (2013) 1.45

Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat (2010) 1.45

A bias in genotyping the ERBB2 (HER2) Ile655Val variant. Carcinogenesis (2005) 1.44

Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer (2008) 1.44

Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Breast Cancer Res Treat (2009) 1.42

Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41

Association of first ocular melanoma with subsequent cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer (2003) 1.41

Gender effects in familial cancer. Int J Cancer (2002) 1.41

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum Mol Genet (2008) 1.40

Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer (2003) 1.39

Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev (2012) 1.39

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer (2006) 1.38

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk. Breast Cancer Res Treat (2010) 1.38

Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst (2008) 1.36

MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis (2007) 1.35

Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci U S A (2008) 1.34

Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst (2007) 1.34

Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood (2005) 1.33

Cancer risks in second-generation immigrants to Sweden. Int J Cancer (2002) 1.33

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer (2007) 1.32

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat (2009) 1.30

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28

Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol (2009) 1.25

The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat (2007) 1.24

Aurora kinases A and B and familial breast cancer risk. Cancer Lett (2006) 1.24

Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis (2007) 1.20

Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis (2006) 1.19

Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol (2010) 1.18

Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev (2008) 1.18

Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis (2005) 1.17

Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev (2003) 1.17

BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol (2004) 1.16

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood (2006) 1.16

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res (2003) 1.16

Familial risk of cancer by site and histopathology. Int J Cancer (2003) 1.15

Cancer risks in ulcerative colitis patients. Int J Cancer (2008) 1.15

p53 autoantibodies predict subsequent development of cancer. Int J Cancer (2005) 1.14

CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer (2002) 1.13

Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer (2003) 1.12

Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer (2006) 1.11

Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int J Cancer (2009) 1.11

Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect (2012) 1.11

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol (2002) 1.11

Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis (2006) 1.11

Familial risks for type 2 diabetes in Sweden. Diabetes Care (2009) 1.10

Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer (2006) 1.10

Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat (2006) 1.10

Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat (2006) 1.10

Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer (2007) 1.09